A Study to Learn if 20vPnC Vaccine was Safe in Healthy Infants and if 20vPnC Produced Antibody Responses Against a Germ called Streptococcus pneumoniae
A Study to Learn if 20vPnC Vaccine was Safe in Healthy Infants and if 20vPnC Produced Antibody Responses Against a Germ called Streptococcus pneumoniae. A Phase 3, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06482077
ClinicalTrials.gov Identifier (NCT): NCT04382326
Protocol ID: B7471011
PrintDownloadOpen Plain Language Summary Result: Click here